REGULATION OF ARGININE-NITRIC OXIDE CYCLE IN BRAIN
REGULATION OF ARGININE-NITRIC OXIDE CYCLE IN BRAIN
批准号:
6301884
负责人:
MARIAN J JACKSON
金额:
$17.82万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-01 至 2001-04-30
关键词:
Downs syndrome aminoacid biosynthesis arginine astrocytes brain metabolism carbon nitrogen ligase enzyme activity enzyme induction /repression glutamine high performance liquid chromatography human tissue laboratory rat lipopolysaccharides messenger RNA microdialysis nitric oxide nitric oxide synthase nitrogen metabolism site directed mutagenesis tissue /cell culture
中文摘要
从精氨酸调节一氧化氮(NO)的合成在以下方面起关键作用:
正常的神经发育、信号传导和大脑对创伤的反应
和感染然而,过量的NO产生(如可能由
创伤或炎性应激)可导致细胞损伤和/或死亡
导致大脑功能受损我们的数据显示精氨酸
合成与一氧化氮合酶(iNOS)协调调节,
在细菌脂多糖或S100 B处理的星形胶质细胞中的诱导。
增强乙酰氨基琥珀酸合成酶(AS),其催化
精氨酸脱氢酶中的限速步骤,促进
瓜氨酸支持精氨酸条件下持续的NO生成
耗尽我们假设,一个尼古丁-一氧化氮循环的功能,
神经组织,以确保精氨酸的可用性不限制NO
合成.有证据表明大脑新陈代谢的改变
作为对这些调解人的回应,
智力迟钝。流行病学研究表明
宫内或围产期感染与智力发育之间的关系
一些非遗传原因的智力迟钝。患者
先天性代谢异常,并发高氨血症
感染被认为是导致神经损伤的原因。S100b
(已被证明诱导神经毒性水平的NO)映射到Down
21号染色体综合征区。它的表达在整个
唐氏综合症患者的发展。在拟议的研究中,我们将
用脂多糖(LPS,模拟感染)干扰脑细胞,或
与S100 B,我们将确定影响的机制,
脑细胞在稳态下合成精氨酸的能力,
应力条件我们将评估可能的划分,
精氨酸和一氧化氮代谢,
大脑的两个区域,其氮能含量不同,
神经元此外,我们将确定LPS刺激的
炎症应激对精氨酸介导的氮代谢的影响
相对于谷氨酰胺合成。LPS和
S100 B协同上调乙酰氨基琥珀酸合成酶和诱导型
星形胶质细胞中的一氧化氮合酶将使用生物化学方法测定。
和分子遗传技术。我们将研究AS酶动力学,
合成和基因表达。这些研究将提供深入了解
脑氮代谢的改变,
感染或创伤,并将奠定基础,设计治疗
限制其神经后果的策略。
英文摘要
Regulated synthesis of nitric oxide (NO) from arginine plays a key role in
normal neural development, signalling, and response of the brain to trauma
and infections. However, excessive NO production (as may result from
trauma or inflammatory stress) can cause cell injury and/or death
resulting in impaired brain function. Our data show that arginine
synthesis is coordinately regulated with nitric oxide synthase (iNOS)
induction in bacterial lipopolysaccharide-or S100B-treated astrocytes.
Augmentation of argininosuccinate synthetase (AS), which catalyzes the
rate-limiting step in arginine synthases, facilitates recycling of
citrulline to support ongoing NO production under conditions of arginine
depletion. We hypothesize that an arginine-nitric oxide cycle functions in
neural tissue to insure that arginine availability does not limit NO
synthesis. Several lines of evidence suggest that altered brain metabolism
in response to these mediators may play a role in the development of
mental retardation. Epidemiological studies have shown an association
between intrauterine or perinatal infectious and development of mental
retardation in some non-genetic causes of mental retardation. For patients
with inborn efforts of metabolism, hyperammonemia during intercurrent
infections is though to be causative in generating neural damage. S100B
(which has been shown to induce neurotoxic levels of NO) maps to the Down
syndrome region of chromosome 21. Its expression is elevated throughout
development in Down Syndrome patients. In the proposed studies we will
perturb brain cells with lipopolysaccharide (LPS, to mimic infection) or
with S100B and we will determine the mechanisms which influence the
capacity of brain cells to synthesize arginine under steady-state and
stress conditions. We will evaluate the possible compartmentation of
arginine and nitric oxide metabolism in cerebral cortex and cerebellum,
two regions of the brain which differ in their content of nitrergic
neurons. In addition, we will determine the effects of LPS-stimulated
inflammatory stress on the flux of nitrogen metabolism through arginine
versus glutamine synthesis. The molecular mechanism(s) by which LPS and
S100B coordinately up-regulate argininosuccinate synthetase and inducible
nitric oxide synthase in astrocytes will be determined using biochemical
and molecular genetic techniques. We will examine AS enzyme kinetics,
synthesis and gene expression. These studies will provide insight into
alterations of brain nitrogen metabolism which occur in response to
infection or trauma and will lay the groundwork for designing therapeutic
strategies to limit their neurological consequences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF ARGININE-NITRIC OXIDE CYCLE IN BRAIN
-
批准号:6108370
-
项目类别:
-
资助金额:$17.82万
-
财政年份:1999
-
负责人:MARIAN J JACKSON
-
依托单位:
REGULATION OF ARGININE-NITRIC OXIDE CYCLE IN BRAIN
-
批准号:6272054
-
项目类别:
-
资助金额:$17.44万
-
财政年份:1998
-
负责人:MARIAN J JACKSON
-
依托单位:
DEVELOPMENTAL REGULATION OF ARGININOSUCCINATE SYNTHETASE
-
批准号:3930657
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARIAN J JACKSON
-
依托单位:
DEVELOPMENTAL REGULATION OF ARGININO SUCCINATE SYNTHETASE
-
批准号:3868898
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARIAN J JACKSON
-
依托单位:
DEVELOPMENTAL REGULATION OF ARGININO-SUCCINATE SYNTHETASE
-
批准号:3909689
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARIAN J JACKSON
-
依托单位:
DEVELOPMENTAL REGULATION OF ARGININO-SUCCINATE SYNTHETASE
-
批准号:3890237
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:MARIAN J JACKSON
-
依托单位:
海外基金